Insider · CIK 0001264908

GRANGE DAVID L

Reports to the SEC for 2 companies · BERKELEY HEIGHTS, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001264908

Forms 4 and 5

Insider transactions

33 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-05-12	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+22.7K sh	—	—	22,700
2025-05-13	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+10K sh	—	—	10,000
2024-05-23	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+105K sh	—	—	104,621
2023-05-08	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+60K sh	—	—	60,000
2022-05-09	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+2.13M sh	—	—	2,131,500
2021-05-10	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+271K sh	—	—	270,882
2020-05-04	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+75K sh	—	—	75,000
2019-05-06	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+30K sh	—	—	30,000
2018-06-12	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+20K sh	—	—	20,000
2018-02-13	TNXPTonix Pharmaceuticals Holding Corp. · Stock OptionA Award	Director	AAward	+7,000 sh	—	—	7,000
2011-02-28	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director, Chief Executive Officer	SSale	−34.5K sh	$26.00	−$897K	61,045
2011-02-28	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−34.5K sh	—	—	69,005
2011-02-28	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+34.5K sh	$20.45	+$706K	95,546
2010-11-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+51.4K sh	$21.98	+$1.13M	112,425
2010-11-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director, Chief Executive Officer	SSale	−51.4K sh	$25.71	−$1.32M	61,045
2010-11-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−51.4K sh	—	—	155,259
2010-11-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−373 sh	—	—	206,639
2010-11-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+373 sh	$21.98	+$8,198.54	61,418
2010-11-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director, Chief Executive Officer	SSale	−373 sh	$26.00	−$9,698	61,045
2010-06-17	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	50,000
2010-02-25	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director, Chief Executive Officer	AAward	+100K sh	—	—	100,000
2009-07-01	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director, Chief Executive Officer	AAward	+200K sh	—	—	200,000
2009-07-01	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director, Chief Executive Officer	AAward	+50K sh	—	—	61,045
2009-01-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director, Chief Executive Officer	AAward	+2,242 sh	—	—	11,045
2008-01-02	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director, Chief Executive Officer	AAward	+1,588 sh	—	—	8,803
2006-01-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director, Chief Executive Officer	AAward	+1,032 sh	—	—	2,612
2005-07-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCM Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	+3,000 sh	$25.76	+$77.3K	4,580
2005-07-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)M Exercise/Conversion	Director, Chief Executive Officer	MExercise/Conversion	−3,000 sh	—	—	15,729
2005-07-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director, Chief Executive Officer	SSale	−1,800 sh	$57.45	−$103K	1,580
2005-07-26	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCS Sale	Director, Chief Executive Officer	SSale	−1,200 sh	$57.44	−$68.9K	3,380
2005-05-18	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Options (to buy)A Award	Director, Chief Executive Officer	AAward	+2,729 sh	—	—	18,729
2005-01-03	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCA Award	Director, Chief Executive Officer	AAward	+1,580 sh	—	—	1,580
2003-10-15	PHARMACEUTICAL PRODUCT DEVELOPMENT, LLCStock Option (to Buy)A Award	Director, Chief Executive Officer	AAward	+8,000 sh	—	—	8,000

Recent filings

Accepted (ET)
May 144
GRANGE DAVID L0001999371-26-010749
SEC(opens sec.gov)
May 154
GRANGE DAVID L0001999371-25-006236
SEC(opens sec.gov)
May 244
GRANGE DAVID L0001999371-24-006620
SEC(opens sec.gov)
May 104
GRANGE DAVID L0001839882-23-012503
SEC(opens sec.gov)
May 114
GRANGE DAVID L0001387131-22-006016
SEC(opens sec.gov)
May 124
GRANGE DAVID L0001387131-21-005545
SEC(opens sec.gov)
May 64
GRANGE DAVID L0001387131-20-004495
SEC(opens sec.gov)
May 84
GRANGE DAVID L0001387131-19-003423
SEC(opens sec.gov)
Jun 134
GRANGE DAVID L0001615774-18-005236
SEC(opens sec.gov)
Feb 154
GRANGE DAVID L0001615774-18-001258
SEC(opens sec.gov)
Mar 14
GRANGE DAVID L0001264908-11-000001
SEC(opens sec.gov)
Nov 44
GRANGE DAVID L0001264908-10-000003
SEC(opens sec.gov)
Jun 184
GRANGE DAVID L0001264908-10-000002
SEC(opens sec.gov)

Companies

Address

C/O TONIX PHARMACEUTICALS HOLDING CORP 200 CONNELL DRIVE, SUITE 3100

BERKELEY HEIGHTS, NJ, 07922